TME

Advertisement
Dec 26 2024HEALTH

The Uncertain Benefits of Ongoing Treatment for Stomach and Pancreas Neuroendocrine Tumors

Stomach and pancreas neuroendocrine tumors are quite the puzzle for doctors. They're not common and often go unnoticed until it's too late, making them difficult to tackle. When these tumors spread, doctors typically start with platinum-based chemotherapy. But here's where it gets confusing. After t

reading time less than a minute
Dec 26 2024HEALTH

Straightening Toes: A Comparison of Orthoses

You might not think much about your toes, but when they're not aligned properly, it can cause pain and discomfort. Hallux valgus is a condition where the big toe points outward and the toe joint sticks out. This study explored how two types of orthoses, or foot supports, can help with this condition

reading time less than a minute
Dec 25 2024HEALTH

Topiramate: A Fresh Look at Treating Kids' Fatty Liver Disease

Fatty liver disease in kids, often linked to obesity, is more common than you might think. While doctors usually suggest lifestyle changes first, these can be tough to stick to. That's where topiramate comes in. This medication is part of a weight loss combo drug for teens aged 12 and up, but docs s

reading time less than a minute
Dec 25 2024HEALTH

Understanding and Managing Complicated Bacterial Infections in the Blood and Heart

Gram-positive bacteria, like Staphylococcus aureus, Streptococcus, and Enterococcus, are commonly behind bloodstream infections and heart inflammations. "Complicated bacteremia" is a term doctors use for S. aureus infections that spread to other parts of the body. This requires longer treatment and

reading time less than a minute
Dec 25 2024HEALTH

Dividing the Bladder Cancer Puzzle: Early Growth vs. Spread

Imagine you're looking at two types of bladder cancer under a microscope. At first glance, they might seem similar, like two plants growing close together. But doctors are trying to figure out how to tell them apart. One type, called "early papillary formation, " grows upward like a tiny stem. The o

reading time less than a minute
Dec 25 2024HEALTH

Testing Larotrectinib: A New Hope for NTRK-Linked Cancers

Scientists are exploring a drug called larotrectinib to fight tumors with a specific gene issue. This drug has shown promise against certain cancers linked to a gene called NTRK. But how well does it work against cancers where NTRK is overactive, not just fused? A new clinical trial is trying to fin

reading time less than a minute
Dec 25 2024HEALTH

Tiny Copper-Gold Nanodots: A New Hope in Cancer Treatment

Have you ever thought about how tiny particles could help fight cancer? Meet gold-infused copper nanodots, also known as Au-doped Cu1. 92S nanodots. These tiny powerhouses have a unique ability to absorb laser light and convert it into heat, which can kill cancer cells. But that's not all! They also

reading time less than a minute
Dec 25 2024HEALTH

New Advances in Pyoderma Gangrenosum Treatment

Pyoderma gangrenosum, or PG, is a skin condition where ulcers grow quickly and hurt a lot. These ulcers have edges that look like they're melting away. The tricky part about PG is that there's no one-size-fits-all treatment. Doctors find it tough because there's not enough solid evidence to guide th

reading time less than a minute
Dec 25 2024HEALTH

Rare Heart Infection from Typhoid: A Survivor's Story

Meet Mr. Johnson, a 67-year-old man who fell ill with fever, diarrhea, and stomach pain. These symptoms lasted for a week before tests showed he had typhoid fever. Typhoid is a disease caused by the bacteria Salmonella Typhi, often spread through contaminated food or water. While usually an intestin

reading time less than a minute
Dec 25 2024HEALTH

Why Biliary Tract Cancer is Often Caught Late

Biliary tract cancer, or BTC, starts in the bile ducts inside the liver (intrahepatic cholangiocarcinoma), the main ducts near the liver (extrahepatic cholangiocarcinoma), or the gallbladder (gallbladder cancer). Because symptoms are often vague and there are no routine screenings, most patients don

reading time less than a minute